StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.57−0.30 (-3.04%)

Close on Nov 18, 2026Market cap $656.27MP/E –Yield –

QuidelOrtho pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

QuidelOrtho's pe ratio was 346.7× on Jan 31, 2024, against 4.6× a year earlier. Over the last 3 years it ranged from 3.1× to 373.0×, with a median of 6.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 2024346.7×−26.3
2023Dec 29, 2023373.0×+368.4
2022Dec 30, 20224.6×−2.6
2021Dec 31, 20217.3×–

More QuidelOrtho figures

See a number that looks wrong?